HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

David S. Knopman, MD

Professor and Consultant, Department of Neurology, Mayo Clinic

Articles

The Aducanumab Saga and the Future of Antiamyloid Monoclonal Antibodies

June 13, 2022

The journey of aducanumab (Aduhelm; Biogen) from development to the FDA is a tortured one, but its path may serve to teach the Alzheimer disease field valuable lessons as it strives forward to develop disease-modifying therapies.